Two recent publications demonstrated that GATA5 hypermethylation in RCC associated with status of metastasis, progressive disease and shortened progression-free survival [23] and that GREM1 hypermethylation in CCRCC.associated with increased Fuhrman grade and decreased overall survival [24]. The gene discussed is GATA5; the disease is renal cell carcinoma.